| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven
|
Izzedine, H.
|
|
|
24 |
9 |
p. 2421-2425
|
artikel
|
| 2 |
Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer
|
Sorbye, H.
|
|
|
24 |
9 |
p. 2354-2360
|
artikel
|
| 3 |
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN
|
Melichar, B.
|
|
|
24 |
9 |
p. 2396-2402
|
artikel
|
| 4 |
A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial
|
Klintman, M.
|
|
|
24 |
9 |
p. 2284-2291
|
artikel
|
| 5 |
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)
|
Groen, H.J.M.
|
|
|
24 |
9 |
p. 2382-2389
|
artikel
|
| 6 |
A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial
|
Johnsson, A.
|
|
|
24 |
9 |
p. 2335-2341
|
artikel
|
| 7 |
A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy †
|
Jiang, Z.-Q.
|
|
|
24 |
9 |
p. 2349-2353
|
artikel
|
| 8 |
A simple and reproducible prognostic index in luminal ER-positive breast cancers
|
Castellano, I.
|
|
|
24 |
9 |
p. 2292-2297
|
artikel
|
| 9 |
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings †
|
Kubicka, S.
|
|
|
24 |
9 |
p. 2342-2349
|
artikel
|
| 10 |
Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191–2200
|
Russi, E.G.
|
|
|
24 |
9 |
p. 2463-2465
|
artikel
|
| 11 |
Bowel perforation in intestinal lymphoma: incidence and clinical features
|
Vaidya, R.
|
|
|
24 |
9 |
p. 2439-2443
|
artikel
|
| 12 |
Cancer and mental health—a clinical and research unmet need
|
Purushotham, A.
|
|
|
24 |
9 |
p. 2274-2278
|
artikel
|
| 13 |
Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph)
|
Kamper-Jørgensen, M.
|
|
|
24 |
9 |
p. 2245-2255
|
artikel
|
| 14 |
Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle
|
Chen, J.H.
|
|
|
24 |
9 |
p. 2329-2335
|
artikel
|
| 15 |
Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
|
Schlesinger, S.
|
|
|
24 |
9 |
p. 2449-2455
|
artikel
|
| 16 |
Editorial board
|
|
|
|
24 |
9 |
p. ii-iii
|
artikel
|
| 17 |
Effect of multiple invasive foci on breast cancer outcomes according to the molecular subtypes: a report from the Korean Breast Cancer Society
|
Moon, H.G.
|
|
|
24 |
9 |
p. 2298-2304
|
artikel
|
| 18 |
Efficacy of multimodal exercise-based rehabilitation on physical activity, cardiorespiratory fitness, and patient-reported outcomes in cancer survivors: a randomized, controlled trial
|
Midtgaard, J.
|
|
|
24 |
9 |
p. 2267-2273
|
artikel
|
| 19 |
Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer
|
Sinn, B.V.
|
|
|
24 |
9 |
p. 2316-2324
|
artikel
|
| 20 |
Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host †
|
Gallagher, D.J.
|
|
|
24 |
9 |
p. 2414-2421
|
artikel
|
| 21 |
HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance
|
Sheng, W.Q.
|
|
|
24 |
9 |
p. 2360-2364
|
artikel
|
| 22 |
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation †
|
Martínez, C.
|
|
|
24 |
9 |
p. 2430-2434
|
artikel
|
| 23 |
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial
|
Bahl, A.
|
|
|
24 |
9 |
p. 2402-2408
|
artikel
|
| 24 |
Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)
|
Dearden, S.
|
|
|
24 |
9 |
p. 2371-2376
|
artikel
|
| 25 |
‘One also needs a bit of trust in the doctor … ’: a qualitative interview study with pancreatic cancer patients about their perceptions and views on information and treatment decision-making
|
Schildmann, J.
|
|
|
24 |
9 |
p. 2444-2449
|
artikel
|
| 26 |
Optimizing treatment of seminoma stage IIA/B step by step
|
Papachristofilou, A.
|
|
|
24 |
9 |
p. 2463
|
artikel
|
| 27 |
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
|
Goldhirsch, A.
|
|
|
24 |
9 |
p. 2206-2223
|
artikel
|
| 28 |
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
|
Schneeweiss, A.
|
|
|
24 |
9 |
p. 2278-2284
|
artikel
|
| 29 |
Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options
|
Aviv, A.
|
|
|
24 |
9 |
p. 2236-2244
|
artikel
|
| 30 |
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma
|
Garcia-Donas, J.
|
|
|
24 |
9 |
p. 2409-2414
|
artikel
|
| 31 |
Renal Ewing tumors †
|
Zöllner, S.
|
|
|
24 |
9 |
p. 2455-2461
|
artikel
|
| 32 |
Results of treatment of advanced-stage lymphoblastic lymphoma at St Jude Children's Research Hospital from 1962 to 2002
|
Sandlund, J.T.
|
|
|
24 |
9 |
p. 2425-2429
|
artikel
|
| 33 |
Role of second-line chemotherapy in advanced pancreatic cancer and its influence on phase II/III study results
|
Teo, M.
|
|
|
24 |
9 |
p. 2462-2463
|
artikel
|
| 34 |
Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer
|
Socinski, M.A.
|
|
|
24 |
9 |
p. 2390-2396
|
artikel
|
| 35 |
Significant efficacy of 2-chlorodeoxyadenosine± rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up
|
Cervetti, G.
|
|
|
24 |
9 |
p. 2434-2438
|
artikel
|
| 36 |
Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma
|
Tsutani, Y.
|
|
|
24 |
9 |
p. 2376-2381
|
artikel
|
| 37 |
Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis
|
|
|
|
24 |
9 |
p. 2466
|
artikel
|
| 38 |
Striving to improve patient-reported outcomes for cancer survivors as the war wages on
|
Albrecht, T.A.
|
|
|
24 |
9 |
p. 2204-2205
|
artikel
|
| 39 |
Table of Contents
|
|
|
|
24 |
9 |
p. iv-vii
|
artikel
|
| 40 |
The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma
|
Kim, H.R.
|
|
|
24 |
9 |
p. 2364-2370
|
artikel
|
| 41 |
Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas
|
Mainetti, L.E.
|
|
|
24 |
9 |
p. 2310-2316
|
artikel
|
| 42 |
Trade-off preferences regarding adjuvant endocrine therapy among women with estrogen receptor-positive breast cancer
|
Wouters, H.
|
|
|
24 |
9 |
p. 2324-2329
|
artikel
|
| 43 |
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy
|
Kurzrock, R.
|
|
|
24 |
9 |
p. 2256-2261
|
artikel
|
| 44 |
Tumour markers fluctuations in patients with medullary thyroid carcinoma receiving long-term RET inhibitor therapy: ordinary lapping or alarming waves foreshadowing disease progression?
|
Postel-Vinay, S.
|
|
|
24 |
9 |
p. 2201-2204
|
artikel
|
| 45 |
Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck
|
Schmitz, S.
|
|
|
24 |
9 |
p. 2261-2266
|
artikel
|
| 46 |
Using one-step nucleic acid amplification (OSNA) for intraoperative detection of lymph node metastasis in breast cancer patients avoids second surgery and accelerates initiation of adjuvant therapy
|
Klingler, S.
|
|
|
24 |
9 |
p. 2305-2309
|
artikel
|
| 47 |
Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain
|
Turner, N.H.
|
|
|
24 |
9 |
p. 2224-2235
|
artikel
|
Tijdschrift beschrijving